Article
Cholinergic muscarinic M4 receptor gene polymorphisms: a potential risk factor and pharmacogenomic marker for schizophrenia.
Schizophrenia research - 1 May 2013
Scarr Elizabeth, Um Jung Yoon, Cowie Tiffany Frances, Dean Brian
Abstract excerpt
Although schizophrenia is a widespread disorder of unknown aetiology, we have previously shown that muscarinic M4 receptor (CHRM4) expression is decreased in the hippocampus and caudate-putamen from subjects with the disorder, implicating the receptor in its pathophysiology. These findings led us to determine whether variation in the CHRM4 gene sequence was associated with an altered risk of schizophrenia by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
